Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: atherosclerosis

February 9, 2026 CD as API / Drug delivery / Pharma applications

CDs for Regulating Cholesterol Homeostasis in Atherosclerosis

The progression of atherosclerosis (AS) is strongly linked to lipid crystals accumulation caused by cholesterol metabolism disorders and the worsening

Continue reading

December 23, 2025 CD as API / CD derivatives / Pharma applications

Multifunctional biomimetic nanocarriers for the treatment of atherosclerosis

Atherosclerosis (AS) has been considered a systemic disease characterized by the excessive generation of reactive oxygen species (ROS) and the

Continue reading

a rat is standing on top of a plastic container
December 18, 2025 CD as API / CD derivatives / Pharma applications

Selective removal of 7-ketocholesterol by a CD-dimer, a novel atherosclerosis therapeutic candidate

The removal of the toxic oxidized cholesterol, 7-ketocholesterol (7KC), from cells through the administration of therapeutics has the potential to

Continue reading

July 8, 2025 Drug delivery / Pharma applications / Uncategorized

Targeted drug delivery systems for atherosclerosis

A review with 402 references Atherosclerosis is a complex cardiovascular disease driven by multiple factors, including aging, inflammation, oxidative stress,

Continue reading

May 12, 2025 CD as API / Drug delivery / Uncategorized

Cyclodextrin Complexes: A New Hope Against Atherosclerosis

Recently, increasing evidence shows that cyclodextrins have an inhibitory effect against atherosclerosis, a chronic disease inducing atherosclerotic cardiovascular diseases (ASCVDs).

Continue reading

January 14, 2025 CD as API / Pharma applications

Cyclodextrin derivative developed by Cyclarity in clinical trial

Cyclarity Therapeutics is pleased to announce regulatory approval to begin its first-in-human clinical trial. The trial will be conducted at CMAX,

Continue reading

November 14, 2024 Drug delivery / Pharma applications

Technological trends in cyclodextrin inclusion complexes for improving cardiovascular drug therapy: A patent review,

Cardiovascular diseases are disorders that compromise the heart and circulatory systems. Ischemic heart disease is one of the causes of

Continue reading

September 26, 2024 CD as API / CD derivatives / Pharma applications

The revival of cyclodextrins as active pharmaceutical ingredients 

Cyclodextrins have long been known as host molecules, a special feature that has led to their widespread use in a

Continue reading

August 8, 2024 CD as API / Pharma applications

Cyclodextrins as therapeutic drugs for treating lipid metabolism disorders

This study sought to systematically compare the efficacy and mechanism of cyclodextrins as drug interventions in lipid metabolism diseases, potentially

Continue reading

July 9, 2024 CD as API / Drug delivery / Pharma applications

Macrophage Membrane-Encapsulated Dopamine-Modified Poly Cyclodextrin Multifunctional Biomimetic Nanoparticles for Atherosclerosis Therapy

Atherosclerotic plaques exhibit high cholesterol deposition and oxidative stress resulting from high reactive oxygen species (ROS). These are the major

Continue reading

Posts pagination

1 2 3 4 Next Posts»

Recent Posts

  • Sugammadex analog water soluble BCD polymer for peptide complexes
  • 2 nd International Conference on Biomedical Science and Engineering
  • Sugammadex vs Neostigmine: Effects on Obese Patients’ Recovery
  • Cyclodextrin-Amino Acid Conjugates
  • Cyclodextrin complexation of selected tyrosine kinase inhibitors

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (64)
  • CD as API (343)
  • CD derivatives (404)
  • Cosmetics and toilettry (49)
  • Diagnosis (12)
  • Drug delivery (784)
  • E-ducation (63)
  • Environmental (132)
  • Events (233)
  • Food (219)
  • Gene delivery (20)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (396)
  • Other industrial use (104)
  • Pharma applications (1,172)
  • Supramolecular systems (40)
  • Uncategorized (143)

Top Posts

  • Sugammadex analog water soluble BCD polymer for peptide complexes
  • Cyclodextrin-Amino Acid Conjugates
  • Cyclodextrin-in-Liposome for therapy: Advances and challenges
  • Pilocarpine eye drops (Vuity)
  • Lanosterol eye drops for cataract treatment
  • Characterization of the substitution pattern of 2-hydroxypropyl-β-cyclodextrin using NMR spectroscopy
  • CDs for the removal of PFAS; A review
  • Appropriate Dosing of Sugammadex in Morbidly Obese Patients
  • Water-Soluble EDTA-Crosslinked Poly-β-Cyclodextrins as Ion-Complexing Drug Carriers.
  • Preparation and characterization of chitosan-citric acid edible films loaded with Cornelian cherry pomace extract as active packaging materials

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,791 other subscribers

Loading Comments...